Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.62 USD | +3.12% | -9.59% | +9.48% |
Apr. 25 | Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer | RE |
Apr. 22 | Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court | MT |
Financials (USD)
Sales 2022 | 254M | Sales 2023 | 193M | Capitalization | 243M |
---|---|---|---|---|---|
Net income 2022 | 6M | Net income 2023 | 2M | EV / Sales 2022 | -0.15 x |
Net cash position 2022 | 456M | Net cash position 2023 | 379M | EV / Sales 2023 | -0.71 x |
P/E ratio 2022 |
67.2
x | P/E ratio 2023 |
106
x | Employees | 203 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.79% |
Latest transcript on Vanda Pharmaceuticals Inc.
1 day | +3.13% | ||
1 week | -9.59% | ||
Current month | +12.41% | ||
1 month | +19.69% | ||
3 months | +23.20% | ||
6 months | +5.24% | ||
Current year | +9.48% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 02-10-31 | |
Kevin Moran
DFI | Director of Finance/CFO | 40 | 12-11-30 |
Scott Howell
HRO | Human Resources Officer | - | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard W. Dugan
BRD | Director/Board Member | 82 | 05-11-30 |
Chief Executive Officer | 64 | 02-10-31 | |
Director/Board Member | 72 | 20-02-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.34% | 29 M€ | -4.33% | ||
0.22% | 27 M€ | -5.03% | - | |
0.05% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 4.62 | +3.12% | 821,939 |
24-04-25 | 4.48 | -1.75% | 923,301 |
24-04-24 | 4.56 | -1.51% | 1,458,632 |
24-04-23 | 4.63 | -3.54% | 1,371,417 |
24-04-22 | 4.8 | -6.07% | 2,114,924 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.48% | 258M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- VNDA Stock